NASDAQ:CBTE

Commonwealth Biotechnologies gets delisting warning

Commonwealth Biotechnologies, a Chesterfield-based biotech firm that has made several international deals lately, received a delisting notice from NASDAQ for failure to meet certain filing rules. The stock is down $0.11, or 17 percent, $0.53 in morning trading. (NASDAQ: CBTE) According to the notice dated July 24, Commonwealth failed to maintain a minimum stockholder’s equity… Read more »

BioTech park lands British firm

A British firm that has come up with a product to kill high-powered bacteria has become the 56th company in the Virginia BioTechnology Research Park in downtown Richmond. Biocontrol Ltd.  of London opened an office in an existing building in the park and will operate as a U.S. based affiliate under the name Biocontrol International… Read more »